PV-10 Effective Against Melanoma

2009-06-02 アップロード · 79 視聴

Provectus Pharmaceuticals, Inc. (OTC BB: PVCT), a development-stage oncology and dermatology biopharmaceutical company, has announced interim data from the first 40 subjects in its Phase 2 clinical trial for the treatment of metastatic melanoma. PV-10 treatment was well tolerated and caused selective tumor destruction in the majority of subjects. Additional data on untreated tumors corroborated observations of a possible bystander effect seen during earlier Phase 1 testing. These data were presented today at the American Society of Clinical Oncology 2009 Annual Meeting, Abstract #9060, entitled “Chemoablation of melanoma with intralesional rose bengal (PV-10)," in the General Poster Session.

To view Multimedia News Release, go to http://www.prnewswire.com/mnr/pvct/37868/

tag·Provectus,PV,10,treatment,metastatic,melanoma,Multivu,37868

非会員の場合は、名前/パスワードを入力してください。

書き込む
今日のアクセス
10
全体アクセス
133,170
チャンネル会員数
35

My Video

リスト形式で表示 碁盤形式で表示

02:52

공유하기
Qualcomms Mirasol Displays
7年前 · 119 視聴

00:34

공유하기
ESPN: Dads Best Sports Moments
7年前 · 63 視聴

00:30

공유하기
Do You Have What It Takes?
7年前 · 51 視聴

00:15

공유하기
I Don't Recycle, Do You?
7年前 · 35 視聴

03:07

공유하기
Give Outdoor Décor New Splash
7年前 · 37 視聴

02:14

공유하기
Summer of 69: Vegas or Bust
7年前 · 88 視聴

02:28

공유하기
Families Discover Nature Rocks
7年前 · 25 視聴

01:26

공유하기
Smithsonian goes On the Water
7年前 · 30 視聴